Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoChange DetectedAn NIH announcement about changes to NIH websites appears above the 403 error message.SummaryDifference1%

- Check11 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record content with a generic error view. Previously visible content such as PDFs, SAP, protocol, and location details are no longer accessible on the page.SummaryDifference19%

- Check60 days agoChange DetectedThe page’s footer now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small update to the site/template rather than changes to the study information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4, indicating a deployment update rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.